Back

Alaunos Therapeutics prices registered direct offering under Nasdaq rules

Verifying
  • Alaunos Therapeutics, Inc. announced pricing for a registered direct offering.
  • The offering was priced at-the-market under Nasdaq rules.
  • Alaunos provided no transaction size or additional terms in the announcement.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Alaunos Therapeutics prices registered direct offering under Nasdaq rules - CoinPost Terminal